A traveling SARS-CoV-2 laboratory as part of a pandemic response among vulnerable Brazilian populations

• Egile Nagusiak: Maria Carolina Elias (Egilea), Svetoslav Nanev Slavov (Egilea), Alex Ranieri Jeronimo Lima (Egilea), Antonio Jorge Martins (Egilea), Claudia Renata dos Santos Barros (Egilea), Debora Botequio Moretti (Egilea), Eduardo L. Araujo (Egilea), Elaine Cristina Marqueze (Egilea), Gabriela Ribeiro (Egilea), Gabriela Mauric Frossard Ribeiro (Egilea), Jardelina Souza Todao Bernardino (Egilea), Jaqueline Reginato Koser (Egilea), Luan Gaspar Clemente (Egilea), Luiz Aurelio Campos Crispin (Egilea), Luiz Carlos Junior Alcantara (Egilea), Luiz Lehmann Coutinho (Egilea), Marta Giovanetti (Egilea), Quetura Oliveira Silva (Egilea), Raul Machado Neto (Egilea), Ricardo Haddad (Egilea), Simone Kashima (Egilea), Vincent Louis Viala (Egilea), Dimas Tadeu Covas (Egilea), Sandra Coccuzzo Sampaio (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2023-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Brazil has been dramatically hit by the SARS-CoV-2 pandemic and is a world leader in COVID-19 morbidity and mortality. Additionally, the largest country of Latin America has been a continuous source of SARS-CoV-2 variants and shows extraordinary variability of the pandemic strain...